GHRP-6: Reference Overview and Reconstitution Notes

GHRP-6 is a man-made peptide (a small chain of building blocks called amino acids) studied in laboratory research settings. It is not approved by the FDA and is banned in sport under the WADA Prohibited List.

GHRP-6

What it is

GHRP-6 (growth hormone-releasing peptide 6, also called growth hormone-releasing hexapeptide) is a man-made peptide made up of six amino acids (the basic building blocks of proteins). Scientists first described it in the 1980s. It belongs to a group called growth hormone secretagogues, which are compounds that prompt the body to release growth hormone. It works by binding to the ghrelin receptor (also called GHS-R1a), the same docking site used by ghrelin, a natural hormone the body produces.

Research context and categorization

GHRP-6 is generally grouped under the growth hormone secretagogue category. Because it activates the same receptor as the natural hormone ghrelin, it is also studied in connection with appetite, energy use, and the signaling that happens between hormones and the nervous system.

Investigational Research

In published studies, GHRP-6 is most often discussed for its ability to trigger pulsatile release of growth hormone. Think of this like a pump that fires in short bursts rather than flowing steadily. It does this through a pathway that is separate from the one used by growth-hormone-releasing hormone (GHRH), another natural signal the body uses.

Researchers have studied GHRP-6 in cell and animal models in connection with appetite stimulation and cachexia (severe, unintended weight loss and muscle wasting seen in some serious illnesses). It has also been studied for possible protective effects on cells and the heart, such as reducing cell death and oxidative stress (damage caused by harmful molecules, sometimes called free radicals) in ischemia-reperfusion injury models (where tissue is harmed when blood flow is cut off and then restored). Tissue repair and inflammation have been studied as well.

These uses are investigational, meaning they are still being explored. The evidence comes mainly from cells, animals, and early-stage studies. No large human trials have been completed for any treatment use, and none of these effects are confirmed or approved.

Key point: GHRP-6 is an investigational compound. No large-scale human trials have been completed, and it is not FDA-approved for any use.

Status

• Regulatory status: Research-only. GHRP-6 is not FDA-approved for any use and is treated as an investigational compound.
• Sport status: Prohibited under the WADA Prohibited List. It is classified under S2 (Peptide Hormones, Growth Factors, Related Substances, and Mimetics) as a growth hormone secretagogue, and is banned at all times, both in-competition and out-of-competition.

Reconstitution notes (general)

GHRP-6 is usually supplied as a lyophilized (freeze-dried) powder. Before laboratory use in research, it must be reconstituted, meaning mixed back into liquid form. The resulting concentration is a simple ratio: take the milligrams of peptide in the vial and divide by the milliliters of bacteriostatic water added.

For example, 5 mg dissolved in 2.5 mL of bacteriostatic water gives 2 mg/mL. Adding more or less water changes the final concentration, so the amount of water is chosen to reach a convenient working concentration. A reconstitution calculator is available at peptide calculator.

Dilution and handling notes (compound-specific)

Reconstitution Solvent & Ratios

GHRP-6 comes as a freeze-dried powder and must be reconstituted before use. Bacteriostatic water is the commonly used solvent (the liquid used for mixing). It contains a preservative called benzyl alcohol that slows the growth of bacteria. This helps keep the solution usable over several weeks in the refrigerator, which suits a peptide measured out across multiple sessions.

A commonly cited range is roughly 2 mL to 3 mL of bacteriostatic water per 5 mg of peptide. This keeps the concentration in an easy-to-measure range, not too dilute and not too concentrated.

Handling Guidelines

GHRP-6 generally dissolves easily and gives a clear, colorless solution. It does not usually cloud up, gel, or form solids at the concentrations noted above. The main thing to watch is how the vial is handled physically. The peptide is sensitive to rough movement, similar to how shaking a carbonated drink too hard causes problems.

Recommended reconstitution steps include:

• Allow the vial to reach room temperature before adding water.
• Direct the water against the inner wall of the vial.
• Swirl gently rather than shake, since vigorous shaking can cause foaming and stress the peptide.
• Give the vial a short rest to let it fully dissolve.

If the reconstituted solution ever looks cloudy or discolored, or has floating particles, treat that as a sign to discard it rather than try to force it into solution.

Handling and storage

Store reconstituted GHRP-6 in the refrigerator at 2 to 8 degrees Celsius, away from direct light. Wipe the stopper with an alcohol swab before drawing from it, and label the vial with the date it was mixed.

Reconstituted solution is generally considered usable for roughly a four-week refrigerated window. Discard the vial if the contents become cloudy, discolored, or develop floating particles. The dry, unreconstituted powder is more stable. For longer storage, keep it frozen.

Related reading

• Hexarelin
• Humanin
• IGF-1 LR3
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What receptor does GHRP-6 bind to?

GHRP-6 binds to the ghrelin receptor (GHS-R1a), the same site used by the natural hormone ghrelin. This binding triggers pulsatile growth hormone release via a pathway separate from GHRH signaling.

What is GHRP-6's regulatory and sport status?

GHRP-6 is not FDA-approved for any use and is classified as an investigational compound. It is prohibited under the WADA Prohibited List (S2 category) at all times, both in- and out-of-competition.

How do you reconstitute lyophilized GHRP-6 for laboratory research?

Add bacteriostatic water to the lyophilized vial; divide milligrams of peptide by milliliters of water to get concentration. Example: 5 mg dissolved in 2.5 mL yields 2 mg/mL.

What the research community gets wrong about GHRP-6

• Treating GHRP-6 as interchangeable with its relatives. GHRP-6, GHRP-2, hexarelin, and ipamorelin are separate molecules with different sequences and masses. GHRP-6 is the six amino acid peptide His-D-Trp-Ala-Trp-D-Phe-Lys (about 873 Daltons). Do not assume a vial is one just because it is grouped with the others. Label every vial by the exact compound and date it was mixed.
• Thinking a more concentrated solution is somehow stronger. Concentration is only a ratio: milligrams of peptide divided by milliliters of water added. It is chosen for easy, accurate measuring at the bench, not because a higher number makes the peptide do more. The mass of powder in the vial does not change when you add more or less water.
• Believing bacteriostatic water makes a solution last forever. The benzyl alcohol in it slows bacterial growth, but it does not stop the peptide itself from breaking down over time. A reconstituted vial is still time limited and belongs in the refrigerator, not on a shelf indefinitely.
• Assuming a clear solution proves the peptide is fine. Clarity only tells you the powder dissolved. It does not confirm the peptide is intact. What clarity can flag is a problem: if a solution turns cloudy, changes color, or shows floating particles, that is a reason to discard the vial, not to shake it harder.
• Mixing up "research-only" with "approved." GHRP-6 is an investigational compound. It is not FDA-approved for any use, and it sits on the WADA Prohibited List (S2). "Studied in the literature" is not the same as cleared for anything.

From our bench: If you reconstitute GHRP-6 at the bench, we would like your real handling notes. Record the vial label amount in milligrams, the exact milliliters of bacteriostatic water you added, and how long the powder took to fully dissolve with gentle swirling (no shaking). Then note the appearance right after mixing and again after each week of refrigerated storage: still clear and colorless, or any cloudiness, color change, or particles. Send us your measured numbers and observations (not estimates), and we will fold anonymized patterns into this page.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. PubChem CID 9919153: Growth hormone releasing hexapeptide (GHRP-6), C46H56N12O6
5. Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells (PubMed 7772238)
6. Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds (PMC4854984)